CD4+CD28- T cells are expanded in sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 22, Issue 1, 2005, Pages 13-19

  Roberts, Scott D ^a   Kohli, Lisa L ^a   Wood, Karen L ^a   Wilkes, David S ^a   Knox, Kenneth S ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

CD28; Immunosenescence; Interferon; Lymphocytes in sarcoidosis; Sarcoidosis; TNF

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CELL ADHESION MOLECULE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD DONOR; CELL AGING; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL POPULATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATORY CELL; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SARCOIDOSIS; T LYMPHOCYTE ACTIVATION;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 15944399364     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med J 1999; 160: 736-55.
2. Salomon B, Bluestone JA: Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225-52.
3. Girvin AM, Dal Canto MC, Rhee L, et al: A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J Immunol 2000; 164: 136-43.
4. Park W, Wcyand CM, Schmidt D, et al: Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28-T cells. Eur J Immunol 1997; 27: 1082-90.
5. Lampreeht P, Moosig F, Csernok E, et al: CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 2001; 56: 751-7.
6. Pawlik A, Ostanek L, Brzosko I. et al: Therapy with infliximab decreases the CD4+CD28-T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatol Int 2004; 24: 351-4.
7. Markovic-Plese S, Cortese I, Wandinger KP, et al: CD4+CD28-costimulation- independent T cells in multiple sclerosis. J Clin Invest 2001; 108: 1185-94.
8. Liuzzo G, Goronzy JJ, Yang H, et al: Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-8.
9. Effros RB, Boucher N, Porler V et al: Decline in CD28-T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol 1994; 29: 601-9.
10. Choremi-Papadopoulou H, Viglis V, Gargalianos P, et al: Down regulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J Acquir Immune Defic Syndr 1994; 7: 245-53.
11. Wood KL, Hage CA, Knox KS, et al: Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med 2003; 167: 1279-82.
12. Pawlik A, Ostanek L, Brzosko I. et al: The expansion of CD4+CD28-T cells in patients with rheumatoid arthritis. Arthritis Res Ther 2003; 5: R210-13.
13. Twigg HL 3rd Spain BA, Soliman DM, et al: Production of interferon-gamma by lung lymphocytes in HIV-infected individuals. Am J Physiol 1999; 276: L256-62.
14. Salazar-Fontana LI, Sanz E, Merida I, et al: Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis. Clin Immunol 2001; 99: 253-65.
15. Wahlstrom J, Berlin M, Skold CM, et al: Phenorypie analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999; 54: 339-46.
16. Katchar K, Wahlstrom J, Eklund A, et al: Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis. Am J Respir Crit Care Med 2001; 163: 1540-5.
17. Mollers M, Aries SP, Dromann D, et al: Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001; 56: 487-93.
18. Bryl E, Vallejo AN, Wcyand CM, et al: Down-regulation of CD28 expression by TNF-alpha. J Immunol 2001; 167: 3231-8.
19. Vallejo AN, Bryl E, Klarskov K, et al: Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem 2002; 277: 46940-9.
20. Perrin PJ, Lavi E, Rumbley CA, et al: Experimental autoimmune meningitis: a novel neurological disease in CD28-deficient mice. Clin Immunol 1999; 91: 41-9.
21. Tang Q, Henriksen KJ, Boden EK, et al: Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 2003; 171: 3348-52.
22. Salomon B, Lenschow DJ, Rhee L, et al: B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-40.
23. Bour-Jordan H, Blueston JA. CD28 function: a balance of costimulatory and regulatory signals. J Clin Immunol 2002; 22: 1-7.
24. Moosig F, Csernok E, Wang G, et al: Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998; 114: 113-18.
25. Nakajima T, Schulte S, Warrington KJ, et al: T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002; 105: 570-5.
26. Agarwal SK, Marshall GD, Jr. Role of CD28/B7 costimulation in the dexamethasone-induced suppression of IFN-gamma. J Interferon Cytokine Res 2000; 20: 927-34.
27. Zou J, Rudwaleit M, Brandt J, et al: Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Arthritis Rheum 2003; 48: 780-90.
28. Roberts SD, Wilkes DS, Burgett RA, et al: Refractory sarcoidosis responding to infliximab. Chest 2003; 124: 2028-31.